Exploring Psychedelics in Psychiatry

This chapter features a psychiatrist outlining their innovative research on depression and PTSD treatment using substances like ketamine and MDMA. The discussion emphasizes the evolving landscape of psychiatric care and the therapeutic potential of psychedelics, including the recent advancements such as the ketamine-derived nasal spray, Spravato. It also examines the cultural impact and historical context of these substances, shedding light on their dual roles in therapeutic and recreational settings.